Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
07/2003
07/02/2003CN1427839A Charged compounds comprising nucleic acid binding moiety and uses therefor
07/02/2003CN1427838A Hydantoin-containing glucokinase activators
07/02/2003CN1427830A Para-substituted phenylamide glucokinase activators
07/02/2003CN1427829A Substituted phenylacetamides and their use as glucokinase activators
07/02/2003CN1427827A 2-Hydroxy-mutilin carbamate derivatives for antibacterial use
07/02/2003CN1427824A Indole derivatives, process for preparation of same and use thereof
07/02/2003CN1427823A Pyrrolecarboxamides and pyrrolethioamides as fungicides
07/02/2003CN1427718A Pharmaceutical compounds for treating COPD
07/02/2003CN1113059C Pipeazino derivatives as neurokinin antagonists
07/02/2003CN1112849C Use of 1,2,3-thiadiazole carboxylic acid (thio) esters of control of pests
07/02/2003CN1112848C Pest controlling agent containing substituted aminoquinazolone or thioketone derivative or its salt as active component
07/01/2003US6586466 Carbohydrazide-protease inhibitors
07/01/2003US6586456 Corticotropin releasing factor (CRF) antagonists such as (4-(2-chloro-4-methoxy-5-methylphenyl)-5-methylthiazol-2-yl)(( (1-(3-fluoro-4-methylphenyl)-2-methoxyethyl))prop-2-ynylamine, prepared by alkylation with propagyl bromide
07/01/2003US6586453 Substituted thiazoles and the use thereof as inhibitors of plasminogen activator inhibitor-1
07/01/2003US6586431 3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives
07/01/2003US6586424 Anticancer agents; anticholesterol agents
07/01/2003US6586423 Tyrosine kinase inhibitors
07/01/2003US6586368 Condensed heterocylic compounds and herbicides containing them
06/2003
06/26/2003WO2003052058A2 Dinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment
06/26/2003WO2003051873A1 Piperazine compounds and their phamaceutical use
06/26/2003WO2003051872A1 Ethylene diamine derivatives and their use as orexin-receptor antagonists
06/26/2003WO2003051871A1 N-aroyl cyclic amine derivatives and their use as orxin receptor antagonist
06/26/2003WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051833A2 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
06/26/2003WO2003051368A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists
06/26/2003WO2003051276A2 Therapeutic heterocycles
06/26/2003WO2003051274A2 Benzodiazepine derivatives, preparation thereof and use thereof
06/26/2003WO2003040109A3 Quinazoline derivatives as antitumor agents
06/26/2003US20030120080 Such as (2S)-2-((4S)-4-(2,2-difluorovinyl)-2-oxopyrrolidinyl) butanamide; antiepileptic agents; anticonvulsants
06/26/2003US20030120078 For treatment and/or prophylaxis of diabetes mellitus
06/26/2003US20030120072 Such as (4-(3,4-Difluoro-phenyl)-piperazin-1-yl)-((4S ,4aS,8aR)-2-((S)-3-(6-methoxy-pyridin-3-yl)-2-methyl-propyl)-decahydro -isoquinolin-4yl)-methanone for treatment of schizophrenia, depression, anxiety and bipolar disorders
06/26/2003US20030119895 Anticancer agents
06/26/2003US20030119856 Thiazole compounds useful as inhibitors of protein kinase
06/26/2003US20030119852 Pyridine or pyrimidine compounds containing C(=O or =S)-N-S(O)m=o,1,2 group, used as insecticides, fungicides, miticides and parasiticides
06/26/2003US20030119828 Insecticides
06/26/2003US20030119827 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases
06/26/2003US20030119811 Ion channel antagonists that are NMDA antagonists; treatment of migraine, depression, anxiety, schizophrenia, Parkinson's disease, or stroke.
06/26/2003US20030119791 Binding to nuclear receptor proteins; stimulating BMP-2 promoter activity
06/26/2003US20030119788 N-cyanomethyl carbonamides and sulfonamides which are cysteine protease, particularly cathepsin K, inhibitors
06/26/2003US20030119754 Treating respiratory syncytial virus and human parainfluenza virus infections
06/26/2003US20030119671 Thiazole-substituted beta-lactams
06/26/2003US20030119670 Difluoromethyltriazolone compounds, use of the same and intermediates for the production thereof
06/26/2003US20030118916 Optic power controller; chromogen modified polymer
06/26/2003CA2470214A1 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer
06/26/2003CA2468978A1 Therapeutic heterocycles
06/26/2003CA2468448A1 Benzodiazepine derivatives, preparation thereof and use thereof
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/25/2003EP1320611A2 Heterologous production of polyketides
06/25/2003EP1320366A1 Substituted piperidines as melanocortin receptor agonists
06/25/2003EP1320365A1 Substituted azole derivatives as inhibitors of corticotropin releasing factor
06/25/2003EP0946546B1 Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine
06/25/2003EP0906094B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl]propyl amides
06/25/2003CN1426409A Inhibitors of dipeptidyl peptidase IV
06/25/2003CN1426406A Process for producing optically active sulfoxide devivative'
06/25/2003CN1426395A Inhibitors of dipeptidyl peptidase IV
06/25/2003CN1426303A Thiazole, imidazole and oxazole compounds and treatments of disorder associated with protein aging
06/24/2003US6583290 14-methyl epothilone derivatives
06/24/2003US6583288 Hydantoin-containing glucokinase activators
06/24/2003US6583166 Fewer side effects than D2 receptor antagonist neuroleptics; cardiovascular, kidney, central nervous system disorders; 3-(3-((4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)sulfanyl) propyl)-1,3,3a,4,5,9b-hexahydro-2H-benzo(e)indol-2-one
06/24/2003US6583157 Quinolinyl and benzothiazolyl modulators
06/24/2003US6583141 T cell mediated rheumatic diseases
06/24/2003US6583140 2-substituted thiazolidinones as beta-3 adrenergic receptor agonists
06/24/2003CA2063851C Method for producing ethers
06/19/2003WO2003050261A2 (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase
06/19/2003WO2003050116A1 A 5(-4-(2-(n-methyl-n-(2-pyridil)amino)ethoxy)benzyl)thiazolidine-2,4-dione (i) 10-camphorsulphonic acid salt and use against diabetes mellitus
06/19/2003WO2003050115A1 Rosiglitazone citrate and its use as antidiabetic
06/19/2003WO2003050114A1 Sulfate salt of a thiazolidinedione derivative
06/19/2003WO2003050113A1 Hydrogensulfate salt of 5-'4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy!benzyl!thia zolidine-2,4-dione
06/19/2003WO2003050112A1 Toluenesulfonate hydrates of a thiazolidinedione derivative
06/19/2003WO2003050111A1 Toluenesulfonate salts of a thiazolidinedione derivative
06/19/2003WO2003050098A1 2-substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancer
06/19/2003WO2003050096A1 Thiazole derivatives with fungicidal activity
06/19/2003WO2003050095A1 Substituted benzoxazoles and analogues as estrogenic agents
06/19/2003WO2003050090A1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases
06/19/2003WO2003049741A1 Ureas of 2-aminobenzothiazoles as adenosine modulators
06/19/2003WO2003049739A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003WO2003049678A2 Mitotic kinesin inhibitors
06/19/2003WO2003049542A1 Pyrazoles-pyrimidine fungicides
06/19/2003WO2003028650A3 Benzimidazolidinone derivatives as muscarinic agents
06/19/2003US20030114674 2-Hydroxy-mutilin carbamate derivatives for antibacterial use
06/19/2003US20030114668 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists
06/19/2003US20030114667 Reacting heterocycle such as 2-cyanoiminothiazolidine with base in presence of diluent, and subsequently reacting product with mixture of 2-chloro-5-chloromethylpyridine and 2-chloro-5-methylpyridine and corresponding hydrochlorides
06/19/2003US20030114649 Plant fungicide
06/19/2003US20030114517 Substituted urea neuropeptide Y Y5 receptor antagonists
06/19/2003US20030114509 Prophylactic or therapeutic drug for renal diseases
06/19/2003US20030114504 Compositions and methods for the treatment of cancer
06/19/2003US20030114502 Substituted thiazoles and oxazoles as corticotropin releasing hormone ligands
06/19/2003US20030114500 Nitrogen heterocycle inhibitors of aspartyl protease
06/19/2003US20030114489 Asthma therapy; antiallergens; antiinflammatory agents
06/19/2003US20030114473 Anticancer agents
06/19/2003US20030114465 Substituted imidazole neuropeptide Y Y5 receptor antagonists
06/19/2003US20030114463 Tetrahydroindolone and purine derivatives linked to arylpiperazines
06/19/2003US20030114453 Antiinflammatory agents; asthma; skin disorders
06/19/2003US20030114447 Controlling apoptosis; central nervous system disorders
06/19/2003US20030114443 Viricides, Aids therapy
06/19/2003US20030114437 Protease inhibitors
06/19/2003US20030114425 Tiamenidine
06/19/2003US20030114311 Such as 5,6-dichloropyridine-2-carboxylic acid-N-oxide for preemergence application
1 ... 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 ... 628